| Dr Jim Zb Lu, MD | |
|
1000 Corporate Grove Dr, Buffalo Grove, IL 60089-4550 | |
| (224) 588-9940 | |
| (224) 588-9941 |
| Full Name | Dr Jim Zb Lu |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 24 Years |
| Location | 1000 Corporate Grove Dr, Buffalo Grove, Illinois |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073590337 | NPI | - | NPPES |
| 200495730A | Medicaid | IN | |
| 036119395 | Medicaid | IL | |
| 30004059010001 | Medicaid | KS | |
| 000000340880 | Other | IN | ANTHEM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0101X | Pathology - Anatomic Pathology | 04-39675 (Kansas) | Secondary |
| 207ZP0101X | Pathology - Anatomic Pathology | 01059594A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| River's Edge Hospital & Clinic | St peter, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Endoscopy Center Of The North Shore Llc | 8729327101 | 3 |
| George N Atia Md Sc | 2961506670 | 11 |
| Gopath Pathology Associates, Sc | 4688830151 | 4 |
| University Of Kansas School Of Medicine Wichita Medical Practice Assoc | 3577464841 | 52 |
News Archive
As of September 30, 2013, Delmar Pharmaceuticals has cash and equivalents of approximately $5.2 million and its working capital balance is in line with its expectations.
With substandard and counterfeit medicines a dangerous and growing problem in the developing world and elsewhere, identifying new technologies to detect such drugs is an urgent matter. In a new study published in the Journal of Pharmaceutical and Biomedical Analysis, scientists from the U.S. Pharmacopeial Convention (USP) evaluated a handheld Raman device's potential to detect counterfeit and substandard medicines.
The current system has resulted in some Ambulance Trusts having to employ dedicated staff dealing exclusively with the paperwork involved to prove that ambulance vehicles are responding to emergencies. The Ambulance Service Association (ASA) estimate that this costs Trusts up to £1million a year.
Health and Human Services Secretary Kathleen Sebelius today announced the release of proposed regulations that will govern how states are to set up and run new marketplaces where individuals and small businesses can shop for health insurance.
Researchers from The University of Colorado, in collaboration with St Vincent's Institute of Medical Research in Melbourne, have identified what may be the initial target of the immune response that causes type 1 diabetes.
› Verified 1 days ago
| Entity Name | Lakeshore Gastroenterology And Liver Disease Institute Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528237765 PECOS PAC ID: 3678564697 Enrollment ID: O20040519000995 |
News Archive
As of September 30, 2013, Delmar Pharmaceuticals has cash and equivalents of approximately $5.2 million and its working capital balance is in line with its expectations.
With substandard and counterfeit medicines a dangerous and growing problem in the developing world and elsewhere, identifying new technologies to detect such drugs is an urgent matter. In a new study published in the Journal of Pharmaceutical and Biomedical Analysis, scientists from the U.S. Pharmacopeial Convention (USP) evaluated a handheld Raman device's potential to detect counterfeit and substandard medicines.
The current system has resulted in some Ambulance Trusts having to employ dedicated staff dealing exclusively with the paperwork involved to prove that ambulance vehicles are responding to emergencies. The Ambulance Service Association (ASA) estimate that this costs Trusts up to £1million a year.
Health and Human Services Secretary Kathleen Sebelius today announced the release of proposed regulations that will govern how states are to set up and run new marketplaces where individuals and small businesses can shop for health insurance.
Researchers from The University of Colorado, in collaboration with St Vincent's Institute of Medical Research in Melbourne, have identified what may be the initial target of the immune response that causes type 1 diabetes.
› Verified 1 days ago
| Entity Name | Shahid Ilahi Md Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629077086 PECOS PAC ID: 3476531534 Enrollment ID: O20040713001501 |
News Archive
As of September 30, 2013, Delmar Pharmaceuticals has cash and equivalents of approximately $5.2 million and its working capital balance is in line with its expectations.
With substandard and counterfeit medicines a dangerous and growing problem in the developing world and elsewhere, identifying new technologies to detect such drugs is an urgent matter. In a new study published in the Journal of Pharmaceutical and Biomedical Analysis, scientists from the U.S. Pharmacopeial Convention (USP) evaluated a handheld Raman device's potential to detect counterfeit and substandard medicines.
The current system has resulted in some Ambulance Trusts having to employ dedicated staff dealing exclusively with the paperwork involved to prove that ambulance vehicles are responding to emergencies. The Ambulance Service Association (ASA) estimate that this costs Trusts up to £1million a year.
Health and Human Services Secretary Kathleen Sebelius today announced the release of proposed regulations that will govern how states are to set up and run new marketplaces where individuals and small businesses can shop for health insurance.
Researchers from The University of Colorado, in collaboration with St Vincent's Institute of Medical Research in Melbourne, have identified what may be the initial target of the immune response that causes type 1 diabetes.
› Verified 1 days ago
| Entity Name | George N Atia Md Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730214271 PECOS PAC ID: 2961506670 Enrollment ID: O20070404000491 |
News Archive
As of September 30, 2013, Delmar Pharmaceuticals has cash and equivalents of approximately $5.2 million and its working capital balance is in line with its expectations.
With substandard and counterfeit medicines a dangerous and growing problem in the developing world and elsewhere, identifying new technologies to detect such drugs is an urgent matter. In a new study published in the Journal of Pharmaceutical and Biomedical Analysis, scientists from the U.S. Pharmacopeial Convention (USP) evaluated a handheld Raman device's potential to detect counterfeit and substandard medicines.
The current system has resulted in some Ambulance Trusts having to employ dedicated staff dealing exclusively with the paperwork involved to prove that ambulance vehicles are responding to emergencies. The Ambulance Service Association (ASA) estimate that this costs Trusts up to £1million a year.
Health and Human Services Secretary Kathleen Sebelius today announced the release of proposed regulations that will govern how states are to set up and run new marketplaces where individuals and small businesses can shop for health insurance.
Researchers from The University of Colorado, in collaboration with St Vincent's Institute of Medical Research in Melbourne, have identified what may be the initial target of the immune response that causes type 1 diabetes.
› Verified 1 days ago
| Entity Name | Gopath Pathology Associates, Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700152311 PECOS PAC ID: 4688830151 Enrollment ID: O20120727000389 |
News Archive
As of September 30, 2013, Delmar Pharmaceuticals has cash and equivalents of approximately $5.2 million and its working capital balance is in line with its expectations.
With substandard and counterfeit medicines a dangerous and growing problem in the developing world and elsewhere, identifying new technologies to detect such drugs is an urgent matter. In a new study published in the Journal of Pharmaceutical and Biomedical Analysis, scientists from the U.S. Pharmacopeial Convention (USP) evaluated a handheld Raman device's potential to detect counterfeit and substandard medicines.
The current system has resulted in some Ambulance Trusts having to employ dedicated staff dealing exclusively with the paperwork involved to prove that ambulance vehicles are responding to emergencies. The Ambulance Service Association (ASA) estimate that this costs Trusts up to £1million a year.
Health and Human Services Secretary Kathleen Sebelius today announced the release of proposed regulations that will govern how states are to set up and run new marketplaces where individuals and small businesses can shop for health insurance.
Researchers from The University of Colorado, in collaboration with St Vincent's Institute of Medical Research in Melbourne, have identified what may be the initial target of the immune response that causes type 1 diabetes.
› Verified 1 days ago
| Entity Name | Endoscopy Center Of The North Shore Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013487388 PECOS PAC ID: 8729327101 Enrollment ID: O20190301000212 |
News Archive
As of September 30, 2013, Delmar Pharmaceuticals has cash and equivalents of approximately $5.2 million and its working capital balance is in line with its expectations.
With substandard and counterfeit medicines a dangerous and growing problem in the developing world and elsewhere, identifying new technologies to detect such drugs is an urgent matter. In a new study published in the Journal of Pharmaceutical and Biomedical Analysis, scientists from the U.S. Pharmacopeial Convention (USP) evaluated a handheld Raman device's potential to detect counterfeit and substandard medicines.
The current system has resulted in some Ambulance Trusts having to employ dedicated staff dealing exclusively with the paperwork involved to prove that ambulance vehicles are responding to emergencies. The Ambulance Service Association (ASA) estimate that this costs Trusts up to £1million a year.
Health and Human Services Secretary Kathleen Sebelius today announced the release of proposed regulations that will govern how states are to set up and run new marketplaces where individuals and small businesses can shop for health insurance.
Researchers from The University of Colorado, in collaboration with St Vincent's Institute of Medical Research in Melbourne, have identified what may be the initial target of the immune response that causes type 1 diabetes.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jim Zb Lu, MD 1359 Barclay Blvd, Buffalo Grove, IL 60089-4501 Ph: (224) 588-9940 | Dr Jim Zb Lu, MD 1000 Corporate Grove Dr, Buffalo Grove, IL 60089-4550 Ph: (224) 588-9940 |
News Archive
As of September 30, 2013, Delmar Pharmaceuticals has cash and equivalents of approximately $5.2 million and its working capital balance is in line with its expectations.
With substandard and counterfeit medicines a dangerous and growing problem in the developing world and elsewhere, identifying new technologies to detect such drugs is an urgent matter. In a new study published in the Journal of Pharmaceutical and Biomedical Analysis, scientists from the U.S. Pharmacopeial Convention (USP) evaluated a handheld Raman device's potential to detect counterfeit and substandard medicines.
The current system has resulted in some Ambulance Trusts having to employ dedicated staff dealing exclusively with the paperwork involved to prove that ambulance vehicles are responding to emergencies. The Ambulance Service Association (ASA) estimate that this costs Trusts up to £1million a year.
Health and Human Services Secretary Kathleen Sebelius today announced the release of proposed regulations that will govern how states are to set up and run new marketplaces where individuals and small businesses can shop for health insurance.
Researchers from The University of Colorado, in collaboration with St Vincent's Institute of Medical Research in Melbourne, have identified what may be the initial target of the immune response that causes type 1 diabetes.
› Verified 1 days ago
Shiwen Song, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1351 Barclay Blvd, Buffalo Grove, IL 60089 Phone: 224-588-9940 Fax: 224-588-9941 | |
Dr. David B. Wilson, MD Pathology Medicare: Medicare Enrolled Practice Location: 1000 Corporate Grove Dr, Buffalo Grove, IL 60089 Phone: 224-588-9940 Fax: 224-588-9941 | |
Dr. Yousef Ebeid Tadros, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1351 Barclay Blvd, Buffalo Grove, IL 60089 Phone: 224-588-9940 Fax: 224-588-9941 |